Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fuji
Boehringer Ingelheim
Deloitte
Argus Health
Cantor Fitzgerald

Generated: April 23, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 211580

« Back to Dashboard

NDA 211580 describes SPY AGENT GREEN KIT, which is a drug marketed by Novadaq Tech and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug. Additional details are available on the SPY AGENT GREEN KIT profile page.

The generic ingredient in SPY AGENT GREEN KIT is indocyanine green. There are three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the indocyanine green profile page.
Summary for 211580
Tradename:SPY AGENT GREEN KIT
Applicant:Novadaq Tech
Ingredient:indocyanine green
Patents:7
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 211580
Suppliers and Packaging for NDA: 211580
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580 NDA Novadaq Technologies Inc 66259-036 66259-036-11 1 KIT in 1 KIT (66259-036-11) * 10 mL in 1 VIAL, PLASTIC * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (66259-146-01)
SPY AGENT GREEN KIT indocyanine green POWDER;INTRAVENOUS, INTERSTITIAL 211580 NDA Novadaq Technologies Inc 66259-036 66259-036-21 6 KIT in 1 CASE (66259-036-21) > 1 KIT in 1 KIT * 10 mL in 1 VIAL, PLASTIC * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (66259-146-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INTRAVENOUS, INTERSTITIALStrength25MG/VIAL
Approval Date:Nov 21, 2018TE:RLD:Yes
Regulatory Exclusivity Expiration:Nov 21, 2021
Regulatory Exclusivity Use:NEW PRODUCT
Patent:➤ Try a Free TrialPatent Expiration:Aug 1, 2021Product Flag?Substance Flag?Delist Request?
Patented Use:VISUALIZATION OF VESSELS, BLOOD FLOW AND TISSUE PERFUSION OF CORONARY ARTERY BYPASS GRAFT IN VASCULAR, GASTROINTESTINAL, ORGAN TRANSPLANT, AND PLASTIC, MICRO- AND RECONSTRUCTIVE, INCLUDING MINIMALLY INVASIVE, SURGERY
Patent:➤ Try a Free TrialPatent Expiration:Sep 22, 2021Product Flag?Substance Flag?Delist Request?
Patented Use:VISUALIZATION OF VESSELS, BLOOD FLOW AND TISSUE PERFUSION OF CARDIOVASCULAR BYPASS GRAFT AND VASCULATURE IN VASCULAR, GASTROINTESTINAL, ORGAN TRANSPLANT, AND PLASTIC, MICRO- AND RECONSTRUCTIVE, INCLUDING MINIMALLY INVASIVE, SURGERY

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
QuintilesIMS
Teva
Fish and Richardson
Cantor Fitzgerald
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.